Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Istanbul - Delayed Quote TRY

Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. (ANGEN.IS)

10.85
-0.09
(-0.82%)
As of 3:10:00 PM GMT+3. Market Open.
Loading Chart for ANGEN.IS
  • Previous Close 10.94
  • Open 10.95
  • Bid 10.87 x --
  • Ask 10.87 x --
  • Day's Range 10.79 - 10.95
  • 52 Week Range 10.31 - 21.12
  • Volume 1,656,843
  • Avg. Volume 6,535,069
  • Market Cap (intraday) 2.387B
  • Beta (5Y Monthly) -0.23
  • PE Ratio (TTM) --
  • EPS (TTM) -0.99
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date May 3, 2023
  • 1y Target Est --

Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S., a biotechnology company, engages in the design, development, and manufacture of real-time PCR kits, nucleic acid extraction kits, and automated nucleic acid extraction instruments in Turkey. It offers microbiology, genetic disorder, panel, sequencing, and food testing kits; and manual spin column and magnetic bead nucleic acid extraction kits, and automated NA extraction instrument kits. The company provides products for diseases, such as brucellosis, chlamydia trachomatis, cytomegalovirus, crimean-congo hemorrhagic fever, novel coronavirus (2019-NCoV)/SARS-CoV-2, epstein-barr virus, hepatitis B, hepatitis C, hepatitis D, herpes simplex virus, human immunodeficiency virus, human papillomavirus, JC and BK polyomaviruses, malaria, measles, meningitis, respiratory infection, parvovirus B19, torque teno virus, toxoplasmosis, tuberculosis, ureaplasma, and west nile virus diseases, as well as factor II, factor V leiden, and methylene-tetra-hydro-folate-reductase mutation diseases. Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. is headquartered in Istanbul, Turkey.

www.anatoliageneworks.com

223

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ANGEN.IS

View More

Performance Overview: ANGEN.IS

Trailing total returns as of 4/30/2025, which may include dividends or other distributions. Benchmark is BIST 100 (XU100.IS) .

YTD Return

ANGEN.IS
12.22%
BIST 100 (XU100.IS)
6.94%

1-Year Return

ANGEN.IS
18.30%
BIST 100 (XU100.IS)
8.93%

3-Year Return

ANGEN.IS
10.50%
BIST 100 (XU100.IS)
276.38%

5-Year Return

ANGEN.IS
3.56%
BIST 100 (XU100.IS)
90.95%

Compare To: ANGEN.IS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ANGEN.IS

View More

Valuation Measures

Annual
As of 4/29/2025
  • Market Cap

    2.41B

  • Enterprise Value

    2.20B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.54

  • Price/Book (mrq)

    1.55

  • Enterprise Value/Revenue

    4.16

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -41.31%

  • Return on Assets (ttm)

    0.58%

  • Return on Equity (ttm)

    -13.25%

  • Revenue (ttm)

    529.83M

  • Net Income Avi to Common (ttm)

    -218.88M

  • Diluted EPS (ttm)

    -0.99

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    221.31M

  • Total Debt/Equity (mrq)

    1.24%

  • Levered Free Cash Flow (ttm)

    -101.16M

Research Analysis: ANGEN.IS

View More

Company Insights: ANGEN.IS

Research Reports: ANGEN.IS

View More

People Also Watch